CEO Thomas Lewis to Retire From Thomas Jefferson University Hospitals in Philadelphia

After more than 20 years at the helm, Thomas J. Lewis will retire from his role as president and CEO of Philadelphia-based Thomas Jefferson University Hospitals, according to a systems news release.

Advertisement

David McQuaid will continue his current role as COO and assume the title of president as well, effective July 1. Mr. McQuaid has served as executive vice president and COO since 2007. Previously, he served as CEO of Durham (N.C.) Regional Hospital — part of the Duke University Health System — and executive VP and COO of Johns Hopkins Bayview Medical Center in Baltimore.

Mr. Lewis was named president in 1990. “Tom’s true impact can be felt daily walking the halls of our hospitals,” William A. Landman, chairman of the board of Thomas Jefferson University Hospitals, said in the release. “His leadership, knowledge and experience will be missed, but we are pleased that he leaves the hospital in good hands.”

Related Articles on Pennsylvania Hospital Executive Moves:

Rose Campbell Named President of Brookville Hospital in Pennsylvania
Penn State Hershey Medical Center Names Dr. Carol Freer CMO
John Kastanis Named Interim CEO of Temple University Hospital

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Executive Moves

  • Tony Torres was named COO of Amarillo-based Northwest Texas Healthcare System, according to an Oct. 12 LinkedIn post. Prior to…

  • Luke Taylor has been named assistant CFO for Indianapolis-based Indiana University Health, according to an Oct. 12 LinkedIn post. Prior…

Advertisement

Comments are closed.